| 30 Sept 2026 | 16:46:14 | Settlement of BSEC Order |
| 15 Sept 2026 | 11:47:43 | Clarification of Press Commentary |
| 26 Jun 2026 | 07:00:03 | Results for the year ended 30 June 2025 |
| 24 Jun 2026 | 07:05:00 | Notification of Preliminary Results and AGM |
| 24 Jun 2026 | 07:04:00 | Q3 Financial Results 2025-26 |
Beximco Pharmaceuticals PLC is a manufacturer and exporter of pharmaceuticals based in Bangladesh. The company produces a wide range of generic medicines, including tablets, capsules, injectables, and inhalers, and also offers contract manufacturing services for global pharmaceutical companies. Beximco Pharma operates in over 50 countries, serving various healthcare markets, and its manufacturing facilities are certified by multiple international regulatory authorities.
| 30 Sept 2026 | 16:46:14 | Settlement of BSEC Order |
| 15 Sept 2026 | 11:47:43 | Clarification of Press Commentary |
| 26 Jun 2026 | 07:00:03 | Results for the year ended 30 June 2025 |
| 24 Jun 2026 | 07:05:00 | Notification of Preliminary Results and AGM |
| 24 Jun 2026 | 07:04:00 | Q3 Financial Results 2025-26 |
Beximco Pharmaceuticals PLC is a manufacturer and exporter of pharmaceuticals based in Bangladesh. The company produces a wide range of generic medicines, including tablets, capsules, injectables, and inhalers, and also offers contract manufacturing services for global pharmaceutical companies. Beximco Pharma operates in over 50 countries, serving various healthcare markets, and its manufacturing facilities are certified by multiple international regulatory authorities.
